title: Biosimilars: what do patients need to consider?
abstract: A view from the EULAR Standing Committee of People with Arthritis/Rheumatism in Europe (SCPARE) on some of the issues that patients might wish to consider about biosimilars in shared decision-making discussions with their rheumatologist. The paper also points to the need for more information on biosimilars being made available in lay language.
authors.forename: Diana
authors.initials: D
authors.lastname: Skingle
keywords: Arthritis; DMARDs (biologic); Patient perspective